Haemonetics HAE Income Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $346.35M+4.8% | $338.97M-2.7% | $327.32M-5.3% | $321.39M-4.4% | $330.6M-3.7% | ||
| $148.14M+7.7% | $136.58M-11.9% | $132.57M-16.1% | $129.15M-19.9% | $137.55M-17.8% | ||
| $198.21M+2.7% | $202.39M+4.6% | $194.74M+3.9% | $192.24M+9.9% | $193.05M+9.7% | ||
| 57.2%-1.2pp | 59.7%+4.2pp | 59.5%+5.2pp | 59.8%+7.8pp | 58.4%+7.2pp | ||
| $14.45M-21.1% | $14.19M-10.4% | $14.87M+5.2% | $16.26M+12.5% | $18.31M+15.4% | ||
| $120.93M+5.0% | $109.15M+2.5% | $101.62M-5.0% | $110.72M+2.3% | $115.14M+5.4% | ||
| $221.24M+81.8% | $134.99M+0.4% | $136.25M+0.4% | $138.37M+2.4% | $121.72M-16.6% | ||
| —— | $67.4M+14.2% | $58.49M+13.1% | $53.87M+35.5% | $71.34M+138% | ||
| -$5.37M-799% | -$7.42M+18.6% | -$7.21M-3.0% | -$8.7M-225% | -$598K+90.8% | ||
| —— | $59.98M+20.1% | $51.29M+14.7% | $45.17M-3.3% | $70.74M+202% | ||
| —— | $15.24M+22.6% | $12.6M+15.9% | $11.14M+33.5% | $12.76M+319% | ||
| —— | $44.74M+19.3% | $38.68M+14.3% | $34.03M-11.3% | $57.98M+185% | ||
| —— | $0.95+28.4% | $0.81+22.7% | $0.70-5.4% | $1.17+192% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Haemonetics's revenue?
- Haemonetics (HAE) generated $1.3B in revenue over the trailing twelve months, down 2.0% year over year.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
